ES530488A0 - Procedimiento para la fabricacion de derivados de plasma - Google Patents

Procedimiento para la fabricacion de derivados de plasma

Info

Publication number
ES530488A0
ES530488A0 ES530488A ES530488A ES530488A0 ES 530488 A0 ES530488 A0 ES 530488A0 ES 530488 A ES530488 A ES 530488A ES 530488 A ES530488 A ES 530488A ES 530488 A0 ES530488 A0 ES 530488A0
Authority
ES
Spain
Prior art keywords
plasma
fractions
pharmacologically
final containers
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530488A
Other languages
English (en)
Other versions
ES8507347A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of ES8507347A1 publication Critical patent/ES8507347A1/es
Publication of ES530488A0 publication Critical patent/ES530488A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES530488A 1983-03-16 1984-03-09 Procedimiento para la fabricacion de derivados de plasma Granted ES530488A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0093283A AT376367B (de) 1983-03-16 1983-03-16 Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten

Publications (2)

Publication Number Publication Date
ES8507347A1 ES8507347A1 (es) 1985-09-01
ES530488A0 true ES530488A0 (es) 1985-09-01

Family

ID=3503162

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530488A Granted ES530488A0 (es) 1983-03-16 1984-03-09 Procedimiento para la fabricacion de derivados de plasma

Country Status (7)

Country Link
US (1) US4608254A (es)
EP (1) EP0119990B1 (es)
JP (1) JPS59181221A (es)
AT (2) AT376367B (es)
CA (1) CA1205012A (es)
DE (1) DE3482306D1 (es)
ES (1) ES530488A0 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK475386D0 (da) 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
US5644032A (en) * 1990-08-06 1997-07-01 Fibrin Corporation Process for producing fibrinogen concentrates
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
EP1565207B1 (en) * 2002-11-25 2006-04-12 Octapharma AG Prekallikrein depleted plasma derived albumin fraction
ES2477294T3 (es) 2007-08-13 2014-07-16 Baxter International Inc Modulación por IVIG de quimioquinas para el tratamiento de la esclerosis múltiple, la enfermedad de Alzheimer y la enfermedad de Parkinson
EP2197487B1 (en) * 2007-09-04 2016-01-06 The Government of The United States of America, as represented by the Secretary, Department of Health and Human Services, Thermal inactivation of rotavirus
NZ629867A (en) 2012-02-29 2016-09-30 Baxalta Inc Igg stimulated remyelination of peripheral nerves

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460137A1 (fr) * 1979-06-29 1981-01-23 Merieux Inst Nouveau medicament a base d'alpha2-macroglobuline, sa preparation et son application
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung

Also Published As

Publication number Publication date
EP0119990A2 (de) 1984-09-26
AT376367B (de) 1984-11-12
CA1205012A (en) 1986-05-27
ATA93283A (de) 1984-04-15
JPS59181221A (ja) 1984-10-15
ES8507347A1 (es) 1985-09-01
EP0119990B1 (de) 1990-05-23
DE3482306D1 (de) 1990-06-28
ATE52919T1 (de) 1990-06-15
US4608254A (en) 1986-08-26
EP0119990A3 (en) 1987-07-01

Similar Documents

Publication Publication Date Title
IT1132101B (it) Procedimento per la produzione di etanolo in forte concentrazione impiegando microorganismi immobilizzati
DE58900776D1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
YU47866B (sh) Postupak za odstranjivanje holesterola i estra holesterola iz žumanca jajeta
ES530488A0 (es) Procedimiento para la fabricacion de derivados de plasma
NL7904097A (nl) Enzymatische microbiologische werkwijze voor de bereiding van optisch aktieve aminozuren uit hydanthoinen en/of racemische carbamoylverbindingen.
ATE1217T1 (de) Verfahren zur isolierung von hbsag.
GB1488774A (en) Hepatitis b antigen and method of producing it
ES535409A0 (es) Procedimiento para pasterizar un plasma de radical-humano
FR2601679B1 (fr) Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
SE7906273L (sv) Sett att framstella en gammaglobulinlosning
NL8400702A (nl) Werkwijze voor de bereiding van carbapenemderivaten.
FR2505868B1 (fr) Procede de modification de la composition de boissons alcoolisees obtenues par fermentation de fruits par utilisation de gaz en etat supercritique
Jones Protein synthesis in bupivacaine (Marcaine)‐treated, regenerating skeletal muscle
FR2539760B1 (fr) Procede de production de methane par fermentation anaerobie
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
RO91666A (ro) Procedeu pentru prepararea unor derivati de acid fenoxiprostatrienoic
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
ATE69816T1 (de) 12- und 13-brom-ergolinderivate.
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
HU175295B (hu) Sposob dlja immobilizacii ili stabilizacii enzimov, ingibitorov i antitel
JPS567721A (en) Preparation of immunoglobulin for intravenous injection
EP0310874A3 (de) Verbessertes Verfahren zur Prüfung von Rohrleitungen
DE3160879D1 (en) Progesterone derivatives, process for their production, and pharmaceutical compositions

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601